Bulletin from the annual general meeting in Alligator Bioscience AB on May 5, 2022
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis ...
Invitation to the Presentation of Alligator Bioscience´s Interim Report January – March 2022 on April 27, 2022
LUND (Sweden) – April 22, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Wednesda ...
Notice of annual general meeting in Alligator Bioscience AB
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis ...
Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences
Lund, Sweden, April 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of the patient enrollment for th ...
Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg
Lund, Sweden, March 23, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the ongoing OPTIMIZE-1 clinical P ...
The Nomination Committee’s proposal regarding the Board of Directors ahead of the Annual General Meeting 2022 in Alligator Bioscience AB
REGULATORY 11 March 2022 Ahead of the Annual General Meeting in Alligator Bioscience AB on May 5, 2022, the Nomination Committee announces i ...
Invitation to the Presentation of Alligator Bioscience´s Year-End Report January – December 2021 on February 11, 2022
LUND (Sweden) – February 4, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Friday ...
Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer
Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), today announ ...
Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB
Lund, Sweden, January 20, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), announces tod ...